A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Clinical trial NCT01692678 · COMPLETED
Trial details
- NCT number
- NCT01692678
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-07
- Primary completion
- 2016-10-11
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.